Business · 16/12/2005Updated: 10/17/2026 · 1 min read
FDA and C-Path Institute Sign Memorandum of Understanding for Collaboration on Medical Product Development
Summary
The US FDA and the C-Path Institute have agreed to collaborate on applied scientific research and training programs to develop new evaluation tools for medical product development, leveraging each party's expertise and resources.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →